CFOR logo

CapForce Inc. Stock Price

OTCPK:CFOR Community·US$182.7m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

CFOR Share Price Performance

US$15.00
14.27 (1,954.79%)
US$15.00
14.27 (1,954.79%)
Price US$15.00

CFOR Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with acceptable track record.

3 Risks
1 Reward

CapForce Inc. Key Details

US$9.0m

Revenue

-US$488.0

Cost of Revenue

US$9.0m

Gross Profit

US$2.3m

Other Expenses

US$6.7m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
0.55
100.01%
74.56%
0%
View Full Analysis

About CFOR

Founded
2001
Employees
1
CEO
Christian-Laurent Bonte
WebsiteView website
www.opgen.com

CapForce Inc., a precision medicine company, develops and commercializes molecular microbiology solutions for life threatening infectious diseases in the United States and internationally. The company’s products include Unyvero application cartridges, Unyvero systems, Acuitas AMR Gene Panel test products, and SARS CoV-2 test kits. It also provides laboratory services; collaboration services, including funded software arrangements; and license arrangements services. In addition, the company offers listing sponsorship and consultancy services. CapForce Inc. was formerly known as OpGen, Inc. and changed its name to CapForce Inc. in February 2026. CapForce Inc. was incorporated in 2001 and is based in Clarksburg, Maryland.

Recent CFOR News & Updates

Recent updates

No updates